Ionis Pharmaceuticals Inc Earnings

The next earnings date for Ionis Pharmaceuticals Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ionis Pharmaceuticals Inc Earnings

Report DateEstimated Earnings Per Share
10/30/2025$-1.23

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ionis Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/30/2025---$0.70391.67%
05/05/2025Before Market$-0.928.47%
02/19/2025Before Market$-0.4349.03%
11/06/2024Before Market$-0.9518.10%
08/01/2024Before Market$-0.4551.09%
05/07/2024Before Market$-0.986.67%
02/21/2024Before Market$-0.0692.77%
11/02/2023Before Market$-1.030.96%
08/09/2023Before Market$-0.6033.33%
05/03/2023Before Market$-0.874.40%
02/22/2023Before Market$-1.36-47.83%
11/09/2022Before Market$-0.3355.41%
08/09/2022Before Market$-0.74-19.35%
05/04/2022Before Market$-0.4635.21%
02/24/2022Before Market$1.41403.57%
11/03/2021Before Market$-0.58-9.43%
08/04/2021Before Market$-0.575.00%
05/05/2021Before Market$-0.64-20.75%
02/24/2021Before Market$0.4457.14%
11/04/2020Before Market$-0.22-144.44%
08/05/2020Before Market$-0.2317.86%
05/06/2020Before Market$-0.35-191.67%
02/26/2020Before Market$1.4151.61%
11/06/2019Before Market$0.18156.25%
08/08/2019Before Market$-0.0196.30%
05/09/2019Before Market$0.625.08%
02/27/2019Before Market$0.19480.00%
11/06/2018Before Market$-0.0381.25%
08/07/2018Before Market$-0.29-222.22%
05/04/2018Before Market$-0.0166.67%
02/27/2018Before Market$0.02100.00%
11/07/2017Before Market$-0.0093.20%
08/08/2017Before Market$-0.09-125.00%
05/09/2017Before Market$0.03-40.00%
02/28/2017Before Market$0.24300.00%
11/09/2016Before Market$0.06-25.00%
08/09/2016Before Market$-0.4711.32%
05/04/2016Before Market$-0.52-4.00%
02/25/2016Before Market$-0.59-22.92%
11/09/2015Before Market$-0.303.23%
08/04/2015Before Market$0.290.00%
05/05/2015Before Market$-0.1430.00%
02/27/2015Before Market$0.16700.00%
11/07/2014Before Market$-0.23-15.00%
08/04/2014---$-0.1023.08%
05/06/2014---$-0.27-12.50%
02/28/2014---$-0.21-23.53%
11/05/2013---$-0.2122.22%
08/06/2013---$-0.0957.14%
05/07/2013---$-0.03-50.00%
02/28/2013---$-0.230.00%
11/06/2012---$-0.33-26.92%
08/06/2012---$-0.0190.00%
05/08/2012---$-0.247.69%
02/29/2012---$-0.20-11.11%
11/07/2011---$-0.27-28.57%
08/04/2011---$-0.1818.18%
05/05/2011---$-0.20-5.26%
02/28/2011---$-0.1436.36%
11/04/2010---$-0.1335.00%
08/09/2010---$-0.25-66.67%
05/06/2010---$-0.1041.18%
03/01/2010---$-0.17-54.55%
11/05/2009---$-0.070.00%
08/06/2009---$-0.03-50.00%
05/07/2009---$1.763.53%
02/25/2009---$-0.09-125.00%
11/10/2008---$0.03160.00%
08/07/2008---$-0.0260.00%
05/12/2008---$-0.0550.00%
03/13/2008---$-0.08-366.67%
11/08/2007---$-1.25-933.33%
08/08/2007---$-0.1323.53%
05/10/2007---$-0.1633.33%
03/08/2007---$-0.18-5.88%
11/02/2006---$-0.1636.00%
08/03/2006---$-0.0389.29%
05/02/2006---$-0.240.00%
03/09/2006---$-0.1131.25%
11/08/2005---$-0.2411.11%
08/08/2005---$-0.34-9.68%
05/05/2005---$-0.52-73.33%
03/01/2005---$-1-127.27%
10/27/2004---$-0.57-32.56%
08/05/2004---$-0.47-2.17%
05/06/2004---$-0.47-14.63%
02/10/2004---$-0.46-15.00%
11/04/2003---$-0.40-5.26%
08/05/2003---$-0.42-7.69%
05/08/2003---$-0.44-37.50%
02/11/2003---$-0.2927.50%
11/06/2002---$-0.33-6.45%
07/30/2002---$-0.39-11.43%
04/23/2002---$-0.340.00%
02/07/2002---$-0.31-72.22%
10/17/2001---$-0.29-26.09%
07/25/2001---$-0.58-34.88%
03/31/2001---$-0.58---
02/07/2001---$-0.40-17.65%
11/02/2000---$-0.1555.88%
08/10/2000---$-0.40-17.65%
05/10/2000---$-0.565.08%
02/10/2000---$-0.58-190.00%
10/27/1999---$-0.444.35%
07/29/1999---$-0.5130.14%
04/29/1999---$-0.47-6.82%
02/17/1999---$-0.62-12.73%
11/03/1998---$-0.0492.31%
07/29/1998---$-0.52-10.64%
04/29/1998---$-0.438.51%
02/09/1998Before Market$-0.41-5.13%
10/22/1997Before Market$-0.0842.86%
07/30/1997Before Market$-0.36-20.00%
05/01/1997Before Market$-0.33-22.22%
02/10/1997---$-0.3211.11%
10/23/1996---$-0.2328.13%
07/24/1996---$-0.29-7.41%
07/26/1995---$-0.309.09%
04/26/1995---$-0.303.23%
02/05/1995---$-0.316.06%
10/30/1994---$-0.2720.59%

More About Ionis Pharmaceuticals Inc

Website
https://www.ionis.com
Country
USA
Full Time Employees
1,069

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); Donidalorsen for patients with hereditary angioedema; and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 that has completed Phase 2 clinical trial for the potential treatment of AS, a rare genetic neurological disease. In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a); Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus; Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as other mid-stage pipeline investigational medicines. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with Metagenomi. The company was incorporated in 1989 and is headquartered in Carlsbad, California.

“Ionis Pharmaceuticals Inc Earnings” Can Refer to the Ionis Pharmaceuticals Inc Earnings Date

Some people say “Ionis Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ionis Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ionis Pharmaceuticals Inc Stock on the Earnings Date

If you own Ionis Pharmaceuticals Inc stock (IONS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ionis Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ionis Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ionis Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Ionis Pharmaceuticals Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.